interferon type I

Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE
Xinyi Zhu, Yashuo Chen, Zhihua Yin, Yutong Zhang, Yiwei Shen, Dai Dai, Xiaojing Lin, Ling-Hua Zou, Nan Shen, Zhizhong Ye, Huihua Ding, Guojun Hou

Lupus Science & Medicine Apr 2024, 11 (1) e001065; DOI: 10.1136/lupus-2023-001065
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease
Scott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie

Lupus Science & Medicine Mar 2024, 11 (1) e001112; DOI: 10.1136/lupus-2023-001112
Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE
Aaron Bao, Michelle A Petri, Andrea Fava, Jun Kang

Lupus Science & Medicine Dec 2023, 10 (2) e001007; DOI: 10.1136/lupus-2023-001007
Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial
Stephen J Balevic, Rachel Randell, Daniel Weiner, Claire Beard, Laura Eve Schanberg, Christoph P Hornik, Michael Cohen-Wolkowiez, Daniel Gonzalez

Lupus Science & Medicine Nov 2022, 9 (1) e000811; DOI: 10.1136/lupus-2022-000811
Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE
Erik W Anderson, Ying Jin, Andrew Shih, Arnon Arazi, Sara Goodwin, Julien Roeser, Richard A Furie, Cynthia Aranow, Bruce Volpe, Betty Diamond, Meggan Mackay

Lupus Science & Medicine Nov 2022, 9 (1) e000808; DOI: 10.1136/lupus-2022-000808
Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren’s syndrome and systemic sclerosis
Rama Andraos, Awais Ahmad, Per Eriksson, Örjan Dahlström, Lina Wirestam, Charlotte Dahle, Roger Hesselstrand, Anders A Bengtsson, Andreas Jönsen, Kristofer Andréasson, Christopher Sjöwall

Lupus Science & Medicine Dec 2022, 9 (1) e000732; DOI: 10.1136/lupus-2022-000732
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Melissa Northcott, Sarah Jones, Rachel Koelmeyer, Julie Bonin, Fabien Vincent, Rangi Kandane-Rathnayake, Alberta Hoi, Eric Morand

Lupus Science & Medicine Feb 2022, 9 (1) e000625; DOI: 10.1136/lupus-2021-000625
Activation-induced colocalisation of SCAMP5 with IFNα in human plasmacytoid dendritic cells
Juliëtte N Pouw, Michel A M Olde Nordkamp, Tom G O'Toole, Timothy R D J Radstake, Emmerik F A Leijten, Marianne Boes

Lupus Science & Medicine Mar 2022, 9 (1) e000680; DOI: 10.1136/lupus-2022-000680
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Raj Tummala, Gabriel Abreu, Lilia Pineda, M Alex Michaels, Rubana N Kalyani, Richard A Furie, Eric F Morand

Lupus Science & Medicine Feb 2021, 8 (1) e000464; DOI: 10.1136/lupus-2020-000464
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
Joseph F Merola, Wenting Wang, Carrie G Wager, Stefan Hamann, Xueli Zhang, Alice Thai, Christopher Roberts, Christina Lam, Cristina Musselli, Galina Marsh, Dania Rabah, Catherine Barbey, Nathalie Franchimont, Taylor L Reynolds

Lupus Science & Medicine Mar 2021, 8 (1) e000428; DOI: 10.1136/lupus-2020-000428

Main menu

interferon type I

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

interferon type I

Pages